Explain How Seebri and Utibron Stack Up Against Other Inhalers for COP

February 2016

Two new bronchodilators, Seebri Neohaler (SEE-bree) and Utibron Neohaler (YOO-tee-bron), will jostle for a place in the COPD market.

They both contain the long-acting anticholinergic, glycopyrrolate...and Utibron combines it with the long-acting beta-agonist, indacaterol.

Think of Seebri as similar to Spiriva (tiotropium), Tudorza (aclidinium), or Incruse (umeclidinium)...and Utibron as similar to Anoro (umeclidinium/vilanterol) or Stiolto (tiotropium/olodaterol).

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote